OTC外用抗真菌薬市場：製品タイプ別、有効成分別、用途別、ユーザー別、流通チャネル別、地域別

OTC外用抗真菌薬の世界市場は、2025年には32億8,000万米ドルと推定され、2032年には49億米ドルに達すると予測され、2025年から2032年までの年間平均成長率（CAGR）は5.9%で成長すると予測されます。

世界のOTC外用抗真菌薬市場は、真菌感染症の有病率の増加と市販薬に対する需要の高まりにより、近年著しい成長を遂げています。外用抗真菌薬は、水虫、白癬、カンジダ症などの様々な真菌感染症を治療するために、皮膚、爪、毛髪に直接塗布する薬剤です。この市場には、クリーム、軟膏、スプレー、パウダーなど幅広い製品があり、処方箋なしで簡単に入手できます。これらの製品の利便性と入手のしやすさが、真菌感染症からの迅速かつ効果的な救済を求める消費者の間で人気を集める一因となっています。個人の衛生とセルフケアに対する意識が高まり続ける中、世界のOTC外用抗真菌薬市場はさらに拡大し、メーカーと小売業者双方にとって有利な機会を提供すると予想されます。

市場力学

世界のOTC外用抗真菌薬市場は、その成長を促進し、課題をもたらし、機会を提供するいくつかの重要な要因の影響を受けています。主な促進要因のひとつは、世界の真菌感染症の増加であり、特に熱帯気候で衛生状態の悪い新興諸国において顕著です。また、真菌感染症にかかりやすくなる糖尿病の罹患率が上昇していることも、市場の成長に寄与しています。さらに、個人の衛生状態や真菌感染症に対する迅速な治療の重要性に対する意識の高まりも、OTC外用抗真菌薬の需要増につながっています。しかし、処方薬や家庭療法などの代替治療オプションが利用可能であるなど、市場には一定の抑制要因があり、これが市場の成長性を制限する可能性があります。さらに、一部の外用抗真菌剤には皮膚刺激やアレルギー反応などの副作用が伴うため、消費者の中にはこれらの製品の使用を控える人もいます。このような課題にもかかわらず、この市場は、特定の消費者のニーズや嗜好に対応する革新的で的を絞った製剤を開発するメーカーにとって大きなビジネスチャンスとなっています。天然およびオーガニックの抗真菌製品に対する需要の増加と新興市場への拡大の可能性は、世界のOTC外用抗真菌薬市場に有望な成長の道を提供しています。

本調査の主な特徴

• 本レポートでは、世界のOTC外用抗真菌薬市場を詳細に分析し、2024年を基準年とした予測期間（2025-2032年）の市場規模（億米ドル）と年間平均成長率（CAGR%）を掲載しています。
• また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案マトリックスについて説明しています。
• また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する主要考察も提供しています。
• 企業ハイライト、製品ポートフォリオ、主要なハイライト、財務実績、戦略などのパラメータに基づいて、世界のOTC外用抗真菌薬市場における主要企業プロファイルを掲載しています。
• 本レポートからの洞察は、マーケティング担当者や企業の経営陣が、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことを可能にするでしょう。
• OTC外用抗真菌剤の世界市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者を対象としています。
• 利害関係者は、世界のOTC外用抗真菌薬市場を分析する際に使用される様々な戦略マトリックスを通じて、意思決定を容易にすることができます。

目次

第1章 調査の目的と前提条件

• 調査目的
• 前提条件
• 略語

第2章 市場の展望

• レポートの説明
  • 市場の定義と範囲
• エグゼクティブサマリー

第3章 市場力学、規制、動向分析

• 市場力学
• 促進要因
• 抑制要因
• 機会
• 影響分析
• 主な発展
• 規制シナリオ
• 製品の発売/承認
• PEST分析
• PORTERの分析
• 合併と買収のシナリオ
• 業界動向

第4章 世界のOTC外用抗真菌薬市場、製品タイプ別、2020年～2032年

• クリーム
• 軟膏
• スプレー
• 粉末
• ゲル
• ローション

第5章 世界のOTC外用抗真菌薬市場、有効成分別、2020年～2032年

• クロトリマゾール
• ミコナゾール
• テルビナフィン
• ケトコナゾール
• トルナフタート
• その他

第6章 世界のOTC外用抗真菌薬市場、用途別、2020年～2032年

• 皮膚糸状菌感染症
• 酵母感染症
• 爪の感染症
• 白癬
• 水虫

第7章 世界のOTC外用抗真菌薬市場、ユーザー別、2020年～2032年

• 大人
• 小児
• 高齢者

第8章 世界のOTC外用抗真菌薬市場、流通チャネル別、2020年～2032年

• オンライン薬局
• 小売薬局
• スーパーマーケット/ハイパーマーケット
• 専門店

第9章 世界のOTC外用抗真菌薬市場、地域別、2020年～2032年

• 北米
  • 米国
  • カナダ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
  • メキシコ
  • その他ラテンアメリカ
• 欧州
  • ドイツ
  • 英国
  • スペイン
  • フランス
  • イタリア
  • ロシア
  • その他欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • オーストラリア
  • 韓国
  • ASEAN
  • その他アジア太平洋地域
• 中東
  • GCC諸国
  • イスラエル
  • その他中東
• アフリカ
  • 南アフリカ
  • 北アフリカ
  • 中央アフリカ

第10章 競合情勢

• Johnson & Johnson
• Bayer AG
• GlaxoSmithKline
• Pfizer Inc.
• Novartis AG
• Merck & Co., Inc.
• Abbott Laboratories
• Sanofi S.A.
• Astellas Pharma Inc.
• Mylan N.V.
• Amgen Inc.
• Teva Pharmaceutical Industries Ltd.
• Valeant Pharmaceuticals International
• Reddy's Laboratories
• Sun Pharmaceutical Industries Ltd.

第11章 アナリストの推奨事項

• 機会
• アナリストの見解
• Coherent Opportunity Map

第12章 参考文献と調査手法

• 参考文献
• 調査手法
• 出版社について

Global OTC Topical Antifungals Market is estimated to be valued at USD 3.28 Bn in 2025 and is expected to reach USD 4.90 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.9% from 2025 to 2032.

The global OTC topical antifungals market has witnessed significant growth in recent years, driven by the increasing prevalence of fungal infections and the rising demand for over-the-counter remedies. Topical antifungals are medications applied directly to the skin, nails, or hair to treat various fungal infections, such as athlete's foot, ringworm, and candidiasis. The market encompasses a wide range of products, including creams, ointments, sprays, and powders, which are readily available without a prescription. The convenience and accessibility of these products have contributed to their popularity among consumers seeking quick and effective relief from fungal infections. As awareness about personal hygiene and self-care continues to grow, the global OTC topical antifungals market is expected to expand further, offering lucrative opportunities for manufacturers and retailers alike.

Market Dynamics

The global OTC topical antifungals market is influenced by several key factors that drive its growth, pose challenges, and present opportunities. One of the primary drivers is the increasing prevalence of fungal infections worldwide, particularly in developing countries with tropical climates and poor hygiene conditions. The rising incidence of diabetes, which makes individuals more susceptible to fungal infections, also contributes to the market's growth. Additionally, the growing awareness about personal hygiene and the importance of prompt treatment for fungal infections has led to a higher demand for OTC topical antifungals. However, the market faces certain restraints, such as the availability of alternative treatment options, including prescription medications and home remedies, which may limit its growth potential. Moreover, the side effects associated with some topical antifungals, such as skin irritation and allergic reactions, may deter some consumers from using these products. Despite these challenges, the market presents significant opportunities for manufacturers to develop innovative and targeted formulations that address specific consumer needs and preferences. The increasing demand for natural and organic antifungal products, as well as the potential for expansion into emerging markets, offers promising avenues for growth in the global OTC topical antifungals market.

Key Features of the Study

• This report provides in-depth analysis of the global OTC topical antifungals market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global OTC topical antifungals market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Johnson & Johnson, Bayer AG, GlaxoSmithKline, Pfizer Inc., Novartis AG, Merck & Co., Inc., Abbott Laboratories, Sanofi S.A., Astellas Pharma Inc., Mylan N.V., Amgen Inc., Teva Pharmaceutical Industries Ltd., Valeant Pharmaceuticals International, Dr. Reddy's Laboratories, and Sun Pharmaceutical Industries Ltd.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global OTC topical antifungals market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global OTC topical antifungals market

Market Segmentation

• Product Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Creams
  • Ointments
  • Sprays
  • Powders
  • Gels
  • Lotions
• Active Ingredient Insights (Revenue, USD Bn, 2020 - 2032)
  • Clotrimazole
  • Miconazole
  • Terbinafine
  • Ketoconazole
  • Tolnaftate
  • Others
• Application Insights (Revenue, USD Bn, 2020 - 2032)
  • Dermatophyte Infections
  • Yeast Infections
  • Nail Infections
  • Ringworm
  • Athlete's Foot
• User Insights (Revenue, USD Bn, 2020 - 2032)
  • Adults
  • Pediatrics
  • Geriatrics
• Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
  • Online Pharmacies
  • Retail Pharmacies
  • Supermarkets/Hypermarkets
  • Specialty Stores
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Johnson & Johnson
  • Bayer AG
  • GlaxoSmithKline
  • Pfizer Inc.
  • Novartis AG
  • Merck & Co., Inc.
  • Abbott Laboratories
  • Sanofi S.A.
  • Astellas Pharma Inc.
  • Mylan N.V.
  • Amgen Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Valeant Pharmaceuticals International
  • Reddy's Laboratories
  • Sun Pharmaceutical Industries Ltd.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global OTC Topical Antifungals Market, By Product Type
  • Global OTC Topical Antifungals Market, By Active Ingredient
  • Global OTC Topical Antifungals Market, By Application
  • Global OTC Topical Antifungals Market, By User
  • Global OTC Topical Antifungals Market, By Distribution Channel
  • Global OTC Topical Antifungals Market, By Region

3. Market Dynamics, Regulations,and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global OTC Topical Antifungals Market, By Product Type, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Creams
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Ointments
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Sprays
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Powders
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Gels
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Lotions
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global OTC Topical Antifungals Market, By Active Ingredient, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Clotrimazole
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Miconazole
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Terbinafine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Ketoconazole
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Tolnaftate
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global OTC Topical Antifungals Market, By Application, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Dermatophyte Infections
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Yeast Infections
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Nail Infections
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Ringworm
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Athlete's Foot
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global OTC Topical Antifungals Market, By User, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Adults
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Pediatrics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Geriatrics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global OTC Topical Antifungals Market, By Distribution Channel, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Supermarkets/Hypermarkets
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Specialty Stores
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global OTC Topical Antifungals Market, By Region, 2020 - 2032, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Active Ingredient, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Active Ingredient, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Active Ingredient, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Active Ingredient, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Active Ingredient, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Active Ingredient, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

10. Competitive Landscape

• Johnson & Johnson
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bayer AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• GlaxoSmithKline
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Pfizer Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Novartis AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Merck & Co., Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Abbott Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Sanofi S.A.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Astellas Pharma Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Mylan N.V.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Amgen Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Teva Pharmaceutical Industries Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Valeant Pharmaceuticals International
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Reddy's Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Sun Pharmaceutical Industries Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

11. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. References and Research Methodology

• References
• Research Methodology
• About us